Allurion's Training Gains SCOPE Accreditation

Scope image
SCOPE_BH_WorldObesityDay_Logo.jpg

Allurion Technologies’ training awarded World Obesity Federation SCOPE accreditation 

  • Allurion’s gold-standard obesity treatment training wins industry seal of approval 
  • Healthcare professionals can now gain CPD points when completing training with Allurion    

NATICK, Mass. -- December 16, 2022 -- The World Obesity Federation (WOF) has given formal accredition to Allurion Technologies for its innovative healthcare training.  

The World Obesity Federation SCOPE Certification is an internationally recognized standard of obesity management expertise that promotes and acknowledges excellence in obesity prevention and treatment training. 

Allurion, a company dedicated to ending obesity, has been awarded 3.5 SCOPE points, which means healthcare providers around the world can now gain Continuing Professional Development (CPD) points for completing their training with Allurion. 

The company runs structured training around the world, designed to empower healthcare professionals to deliver effective behavior change support for their patients on weight-management treatments. The training is open to registered dietitians, psychologists, exercise physiologists, physiotherapists, nurses, health coaches, surgeons, physicians and other professionals working in weight management in more than 60 countries.
 

Products

Camillo Docimo, VP Global Program Excellence & Business Development at Allurion Technologies, said the independent World Obesity Federation accreditation recognized the exceptional value and evidence base that Allurion was bringing to the weight-loss sector.  

“The accreditation recognizes Allurion as offering gold-standard obesity education worldwide,” he said.  

“We work with healthcare professionals to train them to be able to unlock the right behavior change strategies and techniques to help their patients create effective and sustainable habit changes on their weight-loss journey. We focus on helping the participants to develop powerful communication skills and to integrate proven behavior change strategies and techniques into their everyday practice.”  

Zoe Griffiths, Director of Global Nutrition at Allurion Technologies, said the company offered a wide range of training options for healthcare professionals. “What is also unique about our training is that while our company is best known for our swallowable gastric balloon, we work with professionals regardless of the weight management treatment types they offer,” she said.

“It doesn’t matter whether it’s a balloon patient, a bariatric surgery patient or someone receiving dietary support in preparation for another treatment. We train healthcare professionals to create autonomy supportive, patient-centered weight-loss journeys that maximize engagement, optimize outcomes and increase patient satisfaction, in addition to integration of the use of digital tools to power responsible and flexible support for patients. 

“Allowing our training participants to earn CPD certification via our educational initiatives means we can offer thousands of healthcare professionals even more value and recognition for the work they are doing to help people achieve healthy, sustainable weight loss.” 


About World Obesity Federation’s SCOPE accreditation 

To become accredited, training programs are reviewed by the World Obesity Federation’s Clinical Care Committee to ensure they reflect best practices in obesity management and are based on the latest scientific evidence. 

More details: Accreditation | World Obesity Federation 

More details: Certification | World Obesity Federation 


About Allurion

Allurion is dedicated to ending obesity. The Allurion Balloon is the world’s first weight-loss balloon that does not routinely require surgery, endoscopy or anesthesia for placement or removal. It is backed by a full package of support for both patients and clinicians. The Allurion Program features the Allurion gastric balloon, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for clinicians, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan. Patients on the Allurion Program lose an average of 10-15% of their total body weight in 16 weeks.

Learn more about Allurion at www.allurion.com. 

Allurion is a trademark of Allurion Technologies, Inc. in the United States and countries around the world.